Cost comparison between stereotactic large-core-needle biopsy versus surgical excision biopsy in The Netherlands.
Yearly, approximately 7200 Dutch women with non-palpable breast lesions are referred for a diagnostic surgical excision biopsy. Recently, less invasive alternatives such as stereotactic large-core-needle biopsy have emerged. The aim of this study was to compare the costs of surgical excision biopsy and large-core-needle biopsy. As stereotactic equipment is expensive, the costs of large-core-needle biopsy depend on the extent of centralisation of this facility. Therefore, we assessed the extent of economies of scale in four different scenarios of (de)centralisation. We collected cost data in five Dutch hospitals. The cost of surgical excision biopsy amounted to 1184 Euros. In cases where large-core-needle biopsy would be employed decentralised in all 114 hospitals in The Netherlands, the average costs were estimated to be 1186 Euros compared with 572 Euros in a centralised scenario with involvement of 10 hospitals. Therefore, centralisation of stereotactic equipment for core-needle biopsies would be advisable from an economic perspective.
Buijs-van der Woude
T
T
Julius Center for General Practice and Patient Oriented Research, University Medical Center Utrecht, HP D01.335, PO Box 85500, 3508 GA, Utrecht, The Netherlands.
Verkooijen
H M
HM
Pijnappel
R M
RM
Klinkenbijl
J H
JH
Borel Rinkes
I H
IH
Peeters
P H
PH
Buskens
E
E
D001706:Biopsy / Q000191:economics* / Q000379:methods; D001707:Biopsy, Needle / Q000191:economics / Q000379:methods; D001943:Breast Neoplasms / Q000191:economics* / Q000473:pathology; D005260:Female; D017721:Hospital Costs; D006801:Humans; D009426:Netherlands; D012680:Sensitivity and Specificity; D013238:Stereotaxic Techniques / Q000191:economics